Company intelligence / Profile preview
Kimera Labs
Miramar, Florida, United Stateskimeralabs.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Phase 1
01
Overview
Received FDA IND clearance for Phase I/IIa human study of MSC exosomes in May 2023. Currently conducting a 160-patient clinical trial for treating inflammation associated with COVID-19.
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Mesenchymal stem cell (MSC)-derived exosomes
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Kimera Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kimera Labs.